(Q33785861)

29 July 2017

1 reference

title

Gender-related differences in pharmacokinetics and their clinical significance (English)

1 reference

29 July 2017

1 reference

Tanaka E

1

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Journal of Clinical Pharmacy and Therapeutics

29 July 2017

published in

1 reference

29 July 2017

volume

24

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

339-346

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

29 July 2017

1 reference

Molecular genetics and the future of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

The role of individual human cytochromes P450 in drug metabolism and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Genetic polymorphism of S-mephenytoin hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

The drug interaction potential of ranitidine: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Clinically significant pharmacokinetic drug interactions with benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Intersubject and dose-related variability after intravenous administration of erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Alterations in prednisolone disposition as a result of time of administration, gender and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Influence of sex and oral contraceptive steroids on paracetamol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Gender differences in drug metabolism regulated by growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

Effect of age and gender on tirilazad pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.1999.00246.X

10.1046/J.1365-2710.1999.00246.X

21 January 2018

Identifiers

DOI

1 reference

release_faje5sr3pzdjjdgr3yqba6rxsu

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/faje5sr3pzdjjdgr3yqba6rxsu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference